Daniel Botelho Costa, M.D.
|Title||Assistant Professor of Medicine|
|Institution||Beth Israel Deaconess Medical Center|
|Address||Beth Israel Deaconess Med Ctr|
Hematology/Oncology Division, SC 913
330 Brookline Ave
Boston MA 02215
2004||Intern and Resident in Internal Medicine|
2007||Fellow in Hematology/Oncology|
2009||MMSc - Clinical Investigator Training Program|
2010||Staff Physician and Instructor in Medicine|
||Staff Physician and Assistant Professor of Medicine |
Lung cancer is the leading cause of death from cancer in the United States. Better understanding of oncogenes and tumor suppressor genes involved in lung cancer hold the promise of improving clinical care of afflicted patients.
Prior work from our group has focused on transcription factors involved in lung cancer and mechanisms of sensitivity/resistance of oncogene kinases (such as EGFR, ALK, KRAS, ROS1) to tyrosine kinase inhibitors in non-small-cell lung cancer.
Our group is also part of the clinical research effort at DFHCC, with a focus in non-small-cell lung cancer. We are part of the NIH/NCI-funded SPORE in Lung Cancer at DFHCC.
(co-investigators: Daniel G. Tenen, MD, Mark Huberman, MD and Susumu Kobayashi, MD, PhD)
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact Human Resources at faculty_serviceshms.harvard.edu.